Warburg Pincus Acquires JHP Pharmaceuticals for $195M
January 02, 2013
JHP Pharmaceuticals, a specialty pharmaceutical company based out of Parsippany, NJ, has been acquired by Warburg Pincus from Morgan Stanley Principal Investments for $195 million. JHP acquires, develops, manufactures and sells sterile injectable products, with therapeutic solutions for the anesthesiology, gastroenterology, infection disease and women's healthcare markets, among others. The investment will allow JHP to pursue unique partnership and acquisition opportunities in both the branded and generic segments of the market.